These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules. Hasselgren M; Hegedüs L; Godballe C; Bonnema SJ Head Neck; 2010 May; 32(5):612-8. PubMed ID: 19691107 [TBL] [Abstract][Full Text] [Related]
43. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844 [TBL] [Abstract][Full Text] [Related]
44. Medullary Thyroid Carcinoma Associated with Germline RET Xu JY; Grubbs EG; Waguespack SG; Jimenez C; Gagel RF; Sosa JA; Sellin RV; Dadu R; Hu MI; Trotter CS; Jackson M; Rich TA; Hyde SM; Sherman SI; Cote GJ Thyroid; 2016 Dec; 26(12):1744-1751. PubMed ID: 27673361 [TBL] [Abstract][Full Text] [Related]
45. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree]. Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264 [TBL] [Abstract][Full Text] [Related]
46. A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal. Faggiano A; Milone F; Ramundo V; Chiofalo MG; Ventre I; Giannattasio R; Severino R; Lombardi G; Colao A; Pezzullo L J Clin Endocrinol Metab; 2010 Sep; 95(9):E32-6. PubMed ID: 20534767 [TBL] [Abstract][Full Text] [Related]
47. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma. Allen SM; Bodenner D; Suen JY; Richter GT Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888 [TBL] [Abstract][Full Text] [Related]
48. An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature. Cipri C; Vescini F; Torresan F; Pennelli G; Pelizzo MR; Triggiani V; Guastamacchia E; Grimaldi F Endocr Metab Immune Disord Drug Targets; 2019; 19(2):226-229. PubMed ID: 30574858 [TBL] [Abstract][Full Text] [Related]
49. Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Toledo SP; Lourenço DM; Santos MA; Tavares MR; Toledo RA; Correia-Deur JE Clinics (Sao Paulo); 2009; 64(7):699-706. PubMed ID: 19606248 [TBL] [Abstract][Full Text] [Related]
50. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia. Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548 [TBL] [Abstract][Full Text] [Related]
51. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. Niccoli P; Wion-Barbot N; Caron P; Henry JF; de Micco C; Saint Andre JP; Bigorgne JC; Modigliani E; Conte-Devolx B J Clin Endocrinol Metab; 1997 Feb; 82(2):338-41. PubMed ID: 9024213 [TBL] [Abstract][Full Text] [Related]
52. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100 [TBL] [Abstract][Full Text] [Related]
56. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218 [TBL] [Abstract][Full Text] [Related]
57. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma. Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737 [TBL] [Abstract][Full Text] [Related]
58. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center. Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914 [TBL] [Abstract][Full Text] [Related]
59. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes. Skinner MA; Wells SA Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335 [TBL] [Abstract][Full Text] [Related]
60. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer. Diazzi C; Madeo B; Taliani E; Zirilli L; Romano S; Granata AR; De Santis MC; Simoni M; Cioni K; Carani C; Rochira V Endocr Pract; 2013; 19(5):769-79. PubMed ID: 23757613 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]